The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Sokoto, 29 other states endorse state police – Akpabio
- Analyst applauds Adenuga’s contributions to society
- Tinubu nominates 6 NMDPRA directors, seeks Senate confirmation
- Researchers tout biofertilisers, AI to advance Nigerian agriculture, energy
- Nigeria’s menstrual health policy needs prompt implementation, WaterAid says
- Livestock group calls for affordable feed
- Ibrahim Muazzam and the Quest for Philosophical Understanding, by Prof. Jibrin Ibrahim
- NiMet issues Friday-to-Sunday weather forecast
